Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault

Development

Volumn 126, Issue 24, 1999, Pages 5611-5620

  Iseki, S ^a,b   Wilkie, A O M ^c   Morriss Kay, G M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Differentiation; FGFR1; FGFR2; FGFR3; Human; Mouse fetus; Osteogenesis; Proliferation; Skull; Suture

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR RECEPTOR; OSTEONECTIN; OSTEOPONTIN;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE; CELL PROLIFERATION; CRANIOFACIAL SYNOSTOSIS; FETUS; FRONTAL BONE; GENE MUTATION; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKULL DEVELOPMENT; SUTURE; TISSUE DIFFERENTIATION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION; MICE; MICE, INBRED C57BL; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SKULL;

EID: 0033373550     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ali, J., Mansukhani, A. and Basilico, C. (1995). Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4. J. Cell Physiol. 165, 438-448.
2. Beiman, M., Shilo, B. Z. and Volk, T. (1996). Heartless, a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. Genes Dev. 10, 2993-3002.
3. Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A. and Muenke, M. (1996). Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 14, 174-176.
4. Bravo, R. and MacDonald-Bravo, H. (1987). Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol. 105, 1549-1554.
5. Casal, J. and Leptin, M. (1996). Identification of novel genes in Drosophila reveals the complex regulation of early gene activity in the mesoderm. Proc. Natl. Acad. Sci. USA 93, 10327-10332.
6. Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G. and Ornitz, D. M. (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397.
7. Couly, G. F., Coltey, P. M. and Le Douarin, N. M. (1993). The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 117, 409-429.
8. Delezoide, A. L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Vekemans, M. and Bonaventure, J. (1998). Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev. 77, 19-30
9. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996). Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.
10. Dodig, M., Tadic, T., Kronenberg, M. S., Dacic, S., Liu, Y. H., Maxson, R., Rowe, D. W. and Lichtler, A. C. (1999). Ectopic msx2 overexpression inhibits and msx2 antisense stimulates calvarial osteoblast differentiation. Dev. Biol. 209, 298-307.
11. Dono, R., Texido, G., Dussel, R., Ehmke, H. and Zeller, R. (1998). Impaired cerebral cortex development and blood pressure regulation in FGF-2-deticient mice. EMBO J. 17, 4213-25.
12. Drury, R. A. B. and Wallington, E. A. (1967). Carlton's Histological Technique, pp.235-254. New York/Toronto: Oxford University Press.
13. El Ghouzzi, V., Le Merrer, M., Perrin Schmitt, F., Lajeunie, E., Benit, P., Renier, D., Bourgeois, P., Bolcato Bellemin, A. L., Munnich, A. and Bonaventure, J. (1997). Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nature Genet. 15, 42-46.
14. Gilmour, D. T., Lyon, G. J., Carlton, M. B., Sanes, J. R., Cunningham, J. M., Anderson, J. R., Hogan, B. L., Evans, M. J. and Colledge, W. H. (1998). Mice deficient for the secreted glycoprotein SPARC/osteonectin/ BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17, 1860-1870.
15. Goodrich, E. S. (1958). Studies on the Structure and Development of Vertebrates, pp. 230-395. New York: Dover Publications Inc.
16. Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Ortiz de Luna, R. I., Garcia Delgado, C., Gonzalez Ramos, M., Kline, A. D. and Jabs, E. W. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15, 36-41.
17. Hunter, G. K., Hauschka, P. V., Poole, A. R., Rosenberg, L. C. and Goldberg, H. A. (1996). Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 317, 59-64.
18. Iseki, S., Wilkie, A. O. M., Heath, J. K., Ishimaru, T., Eto, K. and Morriss-Kay, G. M. (1997). Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124, 3375-3384.
19. Itoh, N., Mima, T. and Mikawa, T. (1996). Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development 122, 291-300.
20. Kim, H. J., Rice, D. P., Kettunen, P. J. and Thesleff, I. (1998). FGF-, BMP-and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125, 1241-1251.
21. Liu, V. H., Kundu, R., Wu, L., Luo, W., Ignelzi, M. A., Jr., Snead, M. L. and Maxson, R. E., Jr. (1995). Premature sature closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad Sci. USA 92, 6137-6141.
22. Liu, Y. H., Tang, Z., Kundu, R. K., Wu, L., Luo, W., Zhu, D., Sangiorgi, F., Snead, M. L. and Maxson, R. E. (1999). Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. Biol. 205, 260-274.
23. Mehrara, B. J., Mackool, R. J., McCarthy, J. G., Gittes, G. K. and Longaker, M. T. (1998). Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102, 1805-1817.
24. Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S. et al. (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8, 269-274.
25. Opperman, L. A., Sweeney, T. M., Redmon, J., Persing, J. A. and Ogle, R. C. (1993). Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dyn. 198, 312-322.
26. Opperman, L. A., Nolen, A. A. and Ogle, R. C. (1997). TGFβ 1, TGFβ2, and TGFβ3 exhibit distinct patterns of expression during craniofacial suture formation and obliteration in vivo and in vitro. J. Bone Miner. Res. 12, 322-331.
27. Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G. and Goldfarb, M. (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297.
28. Paznekas, W. A., Cunningham, M. L., Howard, T. D., Korf, B. R., Lipson, M. H., Grix, A. W., Feingold, M., Goldberg, R., Borochowitz, Z., Aleck, K., et al. (1998). Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. J. Hum. Genet. 62, 1370-1380.
29. Rittling, S. R., Matsumoto, H. N., McKee, M. D., Nanci, A., An, X. R., Novick, K. E., Kowalski, A. J., Noda, M. and Denhardt, D. T. (1998). Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13, 1101-1111.
30. Rousseau, F., Bonaventure, J., Legeai Mallet, L., Pelet, A., Rozet, J. M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994). Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252-254.
31. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T., Wasmuth, J.J. (1994). Mutations in the transmembrane domain of FGFR3 cause the most common form of dwarfism, achondroplasia. Cell 78, 335-342.
32. Shishido, E., Higashijima, S-i., Emori, Y. and Saigo, K. (1993). Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. Development 117, 751-761.
33. Stark, K. L., McMahon, J. A. and McMahon, A. P. (1991). FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages ot the mouse. Development 113, 641-651.
34. Wall, S. A. (1997). Diagnostic features of the major non-syndromic craniosynostosis and the common deformational conditions which may be confused with them. Curr. Paediat. 7, 8-17.
35. Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P. el al. (1995). Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9, 165-172.
36. Wilkie, A. O. M. (1997). Craniosynostosis: genes and mechanisms. Hum. Mol. Genet. 6, 1647-1656.
37. Xu, X., Weinstein, M., Li, C., Naski, M., Cohen, R. I., Ornitz, D. M., Leder, P. and Deng, C. (1998). Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGK8 and FGF10 is essential for limb induction. Development 125, 753-765.
38. Xhou, M., Sutliff, R. L., Paul, R. J., Lorenz, J. N., Hoying, J. B., Haudenschild, C. C., Yin, M., Coffin, J. D., Kong, L., Kranias, E. G., et al. (1998). Fibroblast growth factor 2 control of vascular tone. Nat. Med. 4, 201-207.